Wednesday, July 8, 2026

biotech · Hypertrophic Cardiomyopathy · Arrhythmogenic Right Ventricular Cardiomyopathy · TNYA

Tenaya Therapeutics

NovaPharmaNews editorial coverage mentioning Tenaya Therapeutics — regulatory, clinical, and market analysis.

South San Francisco, USA HQ
2016 Founded
99 Employees
Public company Type
TNYA · NYSE Ticker
Company details
Status
Public
HQ
South San Francisco, USA
Founded
2016
Employees
99
Programs
2
Drugs
1
Patents
13
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Tenaya Therapeutics — regulatory, clinical, and market coverage.

NovaPharmaNews editorial coverage mentioning Tenaya Therapeutics — regulatory, clinical, and market analysis.

No coverage yet

We have not published news or analysis mentioning Tenaya Therapeutics yet.

Back to company overview →